2026 NPPES data Prosthodontics NPI 1225296353 D.D.S.
Verify on CMS →

AMIRALI ZANDINEJAD, D.D.S.

Prosthodontics in ARLINGTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
156
Medicare Part D claims · 47 beneficiaries · Prosthodontics avg: 85
What the federal data reveals: AMIRALI ZANDINEJAD, D.D.S. is a Prosthodontics ([object Object]) practicing in ARLINGTON, Texas with a Medicare Part D prescribing footprint of 156 claims across 47 beneficiaries .

What the federal data shows

AMIRALI ZANDINEJAD, D.D.S. filed 156 Medicare Part D claims in 2023 as a Prosthodontics in ARLINGTON, Texas.

156
Part D claims, 2023

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AMIRALI ZANDINEJAD, D.D.S. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/27/2008

NPI 1225296353

Primary specialty

Prosthodontics

Niche

3,510 US NPIs in this specialty

Medicare Part D claims

156 84% vs specialty avg

2023 prescription claims

Specialty avg: 85

Specialty distribution in Texas

How Prosthodontics compares to other specialties among Texas providers

Texas providers

Prosthodontics share within Texas

1. Prosthodontics42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Prosthodontics share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Prosthodontics (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Prosthodontics ABMS/AOA estimate

Est. board-certified rate (Prosthodontics) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Prosthodontics) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMIRALI ZANDINEJAD, D.D.S. is a Prosthodontics provider practicing in ARLINGTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.D.S.. NPI: 1225296353. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AMIRALI ZANDINEJAD, D.D.S. appears in the CMS NPPES registry as a Prosthodontics provider holding D.D.S. credentials at 1001 W MITCHELL ST STE 200, ARLINGTON, TX, 76013, with a listed phone of (817) 570-9870. NPI 1225296353 was issued on 05/27/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZANDINEJAD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 156 prescription claims written by this provider, covering 47 Medicare beneficiaries and totaling roughly $599 in drug spend, with an opioid prescribing rate of 26.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Prosthodontics is a narrow specialty nationwide, with 3,510 enrolled providers across 51 states and an average of 85 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1001 W MITCHELL ST STE 200
ARLINGTON, TX 76013

Provider Details

NPI 1225296353
Specialty Prosthodontics
Credentials D.D.S.
Gender Male
NPI Issued 05/27/2008

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to AMIRALI ZANDINEJAD, D.D.S.. To verify AMIRALI ZANDINEJAD, D.D.S.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

156
Total Claims
$599
Total Drug Cost
47
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
156
Total Day Supply
1,562
Brand Drug Cost
$0
Generic Drug Cost
$599
Opioid Claims
41 (26.3% rate)
Antibiotic Claims
53

Patient Demographics

Average Patient Age
70.7 years
Avg HCC Risk Score
1.42
Gender Split
53% female / 47% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Chlorhexidine Gluconate
56
Amoxicillin
47
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
36

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Prosthodontics Overview

How AMIRALI ZANDINEJAD, D.D.S. fits within the Prosthodontics landscape nationally.

3,510
Prosthodontics Providers in US
51
States with Prosthodontics
85
Avg Claims per Provider

AMIRALI ZANDINEJAD, D.D.S.'s 156 claims are above the specialty average of 85.

Nearby Prosthodontics Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ZANDINEJAD.

Compare Prosthodontics nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMIRALI ZANDINEJAD, D.D.S.'s specialty?
AMIRALI ZANDINEJAD, D.D.S. specializes in Prosthodontics and practices in ARLINGTON, Texas. Credentials: D.D.S..
How much does AMIRALI ZANDINEJAD, D.D.S. prescribe under Medicare Part D?
In 2023, AMIRALI ZANDINEJAD, D.D.S. wrote 156 Medicare Part D claims totaling $599 in drug costs for 47 beneficiaries.
Where is AMIRALI ZANDINEJAD, D.D.S. located?
AMIRALI ZANDINEJAD, D.D.S. is located at 1001 W MITCHELL ST STE 200, ARLINGTON, TX, 76013. Phone: (817) 570-9870.
What is AMIRALI ZANDINEJAD, D.D.S.'s NPI number?
AMIRALI ZANDINEJAD, D.D.S.'s National Provider Identifier (NPI) is 1225296353, issued on 05/27/2008.
Does AMIRALI ZANDINEJAD, D.D.S. prescribe opioids?
Yes, AMIRALI ZANDINEJAD, D.D.S. had 41 opioid claims in 2023 with an opioid prescribing rate of 26.3%.
How many Prosthodontics providers are there in the US?
There are 3,510 Prosthodontics providers across 51 states in the US. The average Prosthodontics provider writes 85 Medicare Part D claims per year.
What drugs does AMIRALI ZANDINEJAD, D.D.S. prescribe most often?
Based on 2023 Medicare Part D data, AMIRALI ZANDINEJAD, D.D.S.'s most frequently prescribed drugs include Chlorhexidine Gluconate, Amoxicillin, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMIRALI ZANDINEJAD, D.D.S. accept Medicare?
AMIRALI ZANDINEJAD, D.D.S. appears in CMS Medicare data with 156 Part D claims and 47 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMIRALI ZANDINEJAD, D.D.S.'s credentials?
AMIRALI ZANDINEJAD, D.D.S.'s NPI is 1225296353 with credentials D.D.S.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology